Our 2021 Lymphoma Education for Nurses programme focuses on the value and impact of enhanced support and palliative care for patients with lymphoma, and how the specialist nurse is uniquely placed to coordinate this level of support.
Individualised care is a cornerstone of what specialist nurses aim to deliver to all of their patients receiving a lymphoma diagnosis. The value of early access to enhanced supportive care – at diagnosis and before crisis point – and the timely introduction of palliative care, has countless benefits for the individual, their experience of lymphoma and it’s management, their family, and for their healthcare team. Having the resources and opportunity to embed this service in practice can be challenging, and requires good structures and support systems to be in place. Join us as we discuss these issues, and hear from expert speakers about their evidence, insights, experiences and levers for delivering this enhanced service.
Book your place online (FREE)
2pm: Welcome from chair and introduction to Lymphoma Action - Dallas Pounds, Director of services, Lymphoma Action
2.10pm: Enhanced Supportive Care and its role in lymphoma management - Dr Dan Monnery Palliative Care Consultant and NHS England National Clinical Advisor for Enhanced Supportive Care.
2.50pm: Q&A for Dan
3.10pm: Improving patient care and the role of communication in delivering individualised services - Dr Karen Campbell, Associate Professor in Nursing, Edinburgh Napier University and secretary at UKONS.
3.50pm: Q&A for Karen
4.15pm: Interactive discussion on the topics above
(Please note that this is a draft programme and could be subject to change)
Dr Dan Monnery Palliative Care Consultant and NHS England National Clinical Advisor for Enhanced Supportive Care.
Dan Monnery is a consultant in palliative medicine at The Clatterbridge Cancer Centre in Liverpool and the national advisor for Enhanced Supportive Care (ESC). His clinical work focusses on early intervention through ESC outpatient clinics and complex inpatient symptom management. Dan’s non-clinical interest is in development of quantitative outcome measures from ESC and palliative care interventions and finding models of care which best serve patients’ varying needs through treatment and beyond.
Dr Karen Campbell, Associate Professor in Nursing, Edinburgh Napier University and secretary at UKONS.
Karen is as an Associate Professor in Nursing at Edinburgh Napier University and is the secretary of UKONS (the United Kingdom Oncology Nursing Society), soon to be President Elect in December. Karen works in partnership with clinical educators and staff, to ensure widening access and lifelong learning, by supporting the development and the delivery of educational initiatives. Recently Karen finished her Clinical Doctorate in Nursing “The haematology cancer patients’ perspective of the process of palliative care in in the last year of their life”. Karen has also been the Principal Investigator on a large programme evaluation in Scotland (2015-2018) on Transforming Care After Treatment(TCAT) through use of the Macmillan recovery package, now personalised care . Karen peer reviews for Cancer Nursing, Cancer Nursing Practice, British Journal of Nursing, and the Journal of Patient Experience.
Dallas Pounds, Director of services, Lymphoma Action
Dallas is Director of Services for Lymphoma Action. A general adult nurse by training, she worked clinically in many areas including haematology and specialist palliative and end of life care before taking up leadership and management positions in the NHS, finally being Chief Operating Officer for adult and children’s community services in Buckinghamshire. Following this, she joined the charitable sector in 2010 as Executive Director of Operations at Terrence Higgins Trust, then joining Royal Trinity Hospice in Clapham Common London as Chief Executive Officer. She has a wide range of operational and strategic skills and knowledge, and has a particular interest is equity, diversity, and inclusion.
With thanks to the following companies for sponsoring this webinar. In accordance with how we work with healthcare and pharmaceutical companies, they have no influence over the content of the information we provide.